Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Protein Crystallography
Sample Management
Personalized Medicine
Functional Screening / DSRT
Single-cell Genomics
Gene Expression
Single-cell Genomics
Synthetic Biology


Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
Access™ Laboratory Workstation
Tempo™ Automation Control Software
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir


Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community


JALA Special Issue
Articles and Other Media
Application Notes
Customer Profiles
Core Labs


Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information


About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Contact and Location
Privacy Policy

ARTICLES and Other Media

featuring the Echo® Acoustic Technology

121 Total Articles and Other Media


121 Total Articles and Other Media


TITLES and AUTHORS Year Link PDF + Abstract
  • Miniaturized Luminescent Metabolism Profiling Assays Shieh J, Worzella T, Gallagher A

    Institution: Promega, Labcyte Inc., Deerac Fluidics

    Publication: APPLICATION NOTE

    2006 PDF abstract

    Cytochrome P450 (CYP) and monoamine oxidases (MAO) are two groups of enzymes that metabolize drugs. The interactions of these enzymes and compounds are studied carefully in early drug discovery to facilitate greater success in clinical trials. Luminescent metabolism assays consist of the P450-Glo™ Screening Systems (Promega, Madison, WI) for CYP 1A2, 2C9, 3A4, 2C19 and 2D6, as well as the MAO-Glo™ Assay System (Promega) for monoamine oxidase A. A collection of drug-like compounds was profiled by IC50 analyses against a panel of seven (7) metabolism assays in 1536-well format using acoustic droplet ejection (ADE) coupled with low-volume reagent dispensers. ADE was performed with the Labcyte® Echo™ 550 acoustic liquid handler and low-volume reagent fills were made with a Deerac Fluidics Equator HTS reagent dispenser. ADE and low-volume reagent dispensing provided total enzyme assay volumes of 5 μL. Final analysis volumes were 10 μL.

    Publication / Type:
    Related Subject:
    CYP450, bioluminescence, ADME, Z',
  • Bioluminescence for Drug Metabolism Profiling Worzella T, Cali J, Cosby N, Shieh J, Gallagher A, Zerzaschnitzhofer G, Titus K

    Institution: Promega, Labcyte Inc., Deerac Fluidics, Tecan AG Corporation, Corning Inc.

    Publication: ARTICLE

    2006 PDF abstract

    This article describes metabolic profiling applications in which compounds are assayed against several different drug metabolizing enzymes on the same assay plate. We obtain potency data for cytochrome P450 (CYP450) and monoamine oxidase A (MAO) using this parallel approach and testing compounds in a dose-response format using both 384-well and 1536-well plate formats. 

    Publication / Type:
    Related Subject:
    cytochrome, bioluminescence, miniaturization, ADME, metabolism
  • Acoustic Droplet Ejection Improves Dose-Response Determinations Olechno J, Ellson R

    Institution: Labcyte Inc.

    Publication: POSTER

    2006 PDF abstract

    Dose-response experiments, such as IC50 analyses, are time- and labor-intensive. They usually require multiple serial dilutions and large amounts of sample. Aqueous serial dilutions of concentrated stock solutions can precipitate or otherwise become biologically unavailable generating false negatives. Serial dilutions may also accumulate significant error. Cross-contamination of wells is a constant possibility. Finally, even low levels of DMSO in the final assay can dramatically affect the apparent activity of the compound especially in the case of cell-based assays. A system incorporating acoustic ejection of nanoliter droplets of active compounds dissolved in DMSO improves IC50 analyses by eliminating accumulated error (CV%<10% over the entire sample concentration range), eliminating compound precipitation in intermediate dilutions, reducing consumables (plastics and solvents), reducing DMSO concentrations in the final assay to significantly less than 1% and reducing the amount of compound used in the analysis to nanomoles.

    Publication / Type:
    Related Subject:
    cost reduction, serial dilution, direct dilution, throughput, DMSO, miniaturization, ADE
  • Improving IC50 Analyses by Reducing Compound Waste, Compound Precipitation, Accumulated Error and Consumables Cost Olechno J, O’Connell J, Shieh J, Bramwell A, Ellson R

    Institution: Labcyte Inc., Bristol-Myers Squibb

    Publication: POSTER

    2006 PDF abstract

    IC50 analyses are typically time- and labor-intensive, requiring multiple dilution steps and significant amounts of sample compound. Aqueous dilutions of concentrated stock solutions can lead to sample precipitation and the generation of false negatives. Multiple serial dilutions result in significant accumulated error. Some compounds may stick to pipette tips, reducing the concentration of the analyte in the dilution and also increasing the possibility of contaminating other dilutions. DMSO levels in the final assay solution can affect the apparent activity of the compound especially in the case of cell-based assays.A system incorporating acoustic ejection of nanoliter droplets of active compounds dissolved in DMSO improves IC50 analyses by eliminating accumulated error (CV%<10% over the entire sample concentration range), eliminating compound precipitation in intermediate dilutions, reducing consumables (plastics and solvents), reducing DMSO concentrations in the final assay to significantly less than 1% and reducing the amount of compound used in the analysis to nanomoles. Quantitative improvements in each of these areas will be shown.

    Publication / Type:
    Related Subject:
    throughput, miniaturization, cost reduction, DMSO, serial dilution, direct dilution, dose-response, IC50
  • Managing Compound Library Health Through Solvent Restoration Ellson R and Shieh J

    Institution: Labcyte Inc.

    Publication: PRESENTATION

    2005 PDF abstract

    - Control of hydration level of DMSO in library stocks

    - Control of the concentration of the compound in library stocks

    - Use of acoustics for determination of hydration and volume

     -Experiment: hydration, dehydration and restoration of DMSO hydration level and compound concentration

    Publication / Type:
    Related Subject:
    Managing Compound Library Health Solvent Restoration
  • Compound Preservation in Closed Loop Screening Ellson R, Kong B, Mutz Mitchell, Miller M, Bramwell A and Jamieson R

    Institution: Labcyte Inc., BMG LABTECH GmbH

    Publication: POSTER

    2005 PDF abstract

    The stage has been set for low-microliter compound storage systems dedicated to closed-loop screening. Reliable low-nanoliter dispensing, robust low-microliter assays and accurate high-density microplate readers were necessary, yet insufficient, precursors to closed-loop screening. Hundreds of assays, each using 5 nL of compound solution extracted from the same well of a 1536-well microplate can address compound availability. The next challenge is to extend compound lifetime. Reduction of solvent hydration and evaporation is essential to ensure compound integrity. We show methods for preserving compound in 1536-well microplates. In particular, a novel room-temperature storage method will be introduced that maintains a dry, dehydrating and DMSO-rich microclimate for all the wells within a 1536-well storage plate. We compare the results from microplates stored with conventional seals or lids to novel techniques. Preservation of compound for use in a closed-loop screening environment where plates are accessed hundreds of times per year will be explored.

    Publication / Type:
    Related Subject:
    Compound Preservation Closed Loop Screening
  • Compound Transfer to 3456-Well Assay Plates Using the Echo™ 550 Masse F, Guiral S, Kargman S, Brideau C

    Institution: Merck Frosst Centre for Therapeutic Research

    Publication: POSTER, SBS 2005

    2005 PDF abstract

    May of the HTS assays at Merck are performed in the 3456-well format to enable rapid screening of the sample collection and to reduce the cost of an HTS campaign. Our laboratory has successfully miniaturized many HTS assays to the 3456 format using Aurora Discovery's Flying Reagent Dispenser™ (FRD) and the tcPR™ detector. However, we did not have the capability to transfer 5nL of compound solutions to the 3456 assay plate. The Echo 550 was chosen to perform this task. We will show reproducibility, accuracy and precision data of the 5nL acoustic droplet ejection into the 3456-well plates using fluorescent dyes. Results from a panel of compounds tested in a 3456-well enzymatic assay will also be presented and compared to the original 384-well format.

    Publication / Type:
    POSTER, SBS 2005
    Related Subject:
    dry dispense, wet dispense, IC50, dose-response, miniaturization, 3456-well plate
  • Miniaturization and Low Volume Liquid Handling Take the Lead in Lab Automation Tulsi B

    Institution: Bioscience Technology


    2005 abstract

    Even a cursory look at the laboratory automation and robotics field will reveal that key recent accomplishments revolve largely around the ability to handle tiny volumes efficiently and accurately and on innovative technologies that render liquid handling systems far more capable. "In the last few years the key advancement in laboratory automation has really come in the miniaturization process, that is, driving down from 384 well plates to 1536 well plates and beyond," says Jonathan O'Connell, PhD, Group Leader in Lead Discovery, Bristol Myers Squibb (BMS).

    Related Subject:
    Miniaturization, automation, integration, DMSO, cost reduction, throughput 
  • Continued Miniaturisation of Assay Technologies Drives Market for NANOLITRE DISPENSING Dr. John Comley

    Institution: Drug Discovery World

    Publication: ARTICLE

    2004 PDF abstract

    The continued miniaturisation of assay technologies in high throughput screening, compound management and protein crystallisation has created a pressing need for improved nanolitre liquid handling systems.A recent industry market survey suggests that although the total liquid handing market in pharma drug discovery is contracting, the nanolitre dispensing segment is expected to grow to $56 million US dollars in 2004 with a 45% annual growth rate. Growth over the next two years is predicted to be especially strong for devices based on acoustic transducers and solenoid sensors.This review takes a look at some of the latest offerings in this increasingly competitive market place and discusses some recent industry trends. Customer expectations have now shifted from lower volumes to improved performance and reliability, added value and maximising the quality to price ratio.

    Publication / Type:
    Related Subject:
    Miniaturisation of Assay Technologies NANOLITRE DISPENSING
  • Acoustic Non-Contact Dispensing- The Right Choice for UHTS Spicer T

    Institution: Bristol-Myers Squibb

    Publication: PRESENTATION

    2004 PDF abstract

    Bristol-Myers Squibb has implemented a flexible, fully automated UHTS process. Key to the process is compound reformatting with the Echo 550 nanoliter dispensing technology. They plan to implement a flexible closed loop screening process. 

    Publication / Type:
    Related Subject:
    Acoustic Non-Contact Dispensing UHTS

Featured Labcyte Downloads
For Research Use Only Not for use in Diagnostics